Project Grant R21NS139109

Award Date 4/25/25
Completion Date 3/31/27
Dollars Obligated $185K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Ohio, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $151,559 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to Rensselaer Polytechnic Institute (RPI) to develop innovative magnetically responsive drug delivery electrospun fibers to improve regeneration after spinal cord injury (SCI). The project aims to create a novel biomaterial system that can release precise dosages of the anti-inflammatory cytokine...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded The Ohio State University a $119,018 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders program. This grant will support research into strategies to interrogate and enhance myelin remodeling in distal tissue after spinal cord injury. The goal of the NINDS program is to fund basic and applied research exploring the brain, nervous system structure...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research to develop a deep single-cell RNA sequencing approach to understand the molecular mechanisms regulating axon regeneration after spinal cord injury. Totaling $1,006,322, the award will support experiments to refine and expand a regeneration classifier built...
The federal Project Grant award R01NS134695, totaling $586,525.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The primary purpose of this grant is to develop a non-invasive infrared light therapy and medical device to treat spinal cord injury (SCI). The project aims to reduce reactive oxygen species production and re-establish...
This $424,875.00 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund a comprehensive study of gene transcription patterns in diverse classes of neurons that connect the brain to the spinal cord after spinal cord injury in a mouse model. The research team at Marquette University will use single-cell sequencing technologies to profile...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports development of a novel screening technology to identify FDA-approved drugs that can promote functional recovery in spinal cord injury (SCI). The $411,136 award to the Texas A&M University System Health Science Center will fund a 3-step screening platform using adult cortical...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, aims to investigate the mechanisms underlying metabolic complications and adipose tissue dysfunction after spinal cord injury (SCI). The $545,612 award, effective September 11, 2024 through August 31, 2025, will support research by The Ohio State University to explore how sensory neuron signaling and voltage-gated calcium channel subunits influence adipose...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program provides funding for a pooled in vivo screening study to identify genetic combination therapies that can enhance axonal regeneration after spinal cord injury (SCI). The $437,250 award to the University of California, San Diego (UCSD) will support a two-part research study....
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $566,089 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program to The Ohio State University. The grant, awarded on September 20, 2024, supports research to understand the impact of pneumonia on neurological recovery following spinal cord injury. The research aims to identify the mechanisms by which acute pneumonia exacerbates spinal cord...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) is focused on developing an injectable hydrogel biomaterial to improve the survival and integration of human induced pluripotent stem cell-derived neurons (hiPSC-neurons) transplanted into the site of spinal cord injuries. The $504,888 award, spanning from June 2024 to April 2027,...

This Project Grant award, titled "Promoting Spinal Cord Repair Using a Polymer-Based Drug Delivery System", is funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $184,837 award aims to develop a novel polymer-based drug delivery system for localized intraspinal administration of gabapentinoid drugs to promote axon regeneration and functional recovery following spinal cord injury (SCI) in adult mice. Key objectives include optimizing the physicochemical properties of the drug-loaded microspheres, and evaluating their efficacy in enhancing axon regeneration and SCI repair in in vitro and in vivo models. The award was granted on April 25, 2025 to The Ohio State University, with a projected completion date of March 31, 2027. This research builds upon the university's expertise in biomedical sciences, drug delivery systems, and spinal cord injury therapeutics to advance potential treatment strategies for traumatic SCI.

Generated 5/13/25, 3:14 AM